METOPROLOL SUCCINATE ER TABLETS

METOPROLOL SUCCINATE ER TABLETS was reported 63972 times

METOPROLOL SUCCINATE ER TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SUSPECTED SUICIDE 375 0.0799
1 BRASH SYNDROME 111 0.0791
2 PERIORBITAL PAIN 48 0.0567
3 ARTERIAL HAEMORRHAGE 49 0.0429
4 ESSENTIAL HYPERTENSION 71 0.0388
5 AORTIC VALVE STENOSIS 59 0.0331
6 OBSTRUCTIVE SLEEP APNOEA SYNDROME 48 0.0329
7 EYELID PAIN 64 0.0315
8 INFUSION SITE DISCHARGE 55 0.0313
9 NEPHROGENIC ANAEMIA 144 0.0311
10 TACHYARRHYTHMIA 76 0.0304
11 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 65 0.0263
12 HYPERPARATHYROIDISM SECONDARY 64 0.0255
13 AORTIC ARTERIOSCLEROSIS 63 0.0245
14 INFUSION SITE HAEMORRHAGE 80 0.0243
15 CHRONIC GASTRITIS 52 0.0230
16 BLOOD PRESSURE INADEQUATELY CONTROLLED 134 0.0223
17 DIASTOLIC DYSFUNCTION 68 0.0220
18 INFUSION SITE BRUISING 46 0.0213
19 DIVERTICULUM INTESTINAL 93 0.0212
20 SEASONAL ALLERGY 291 0.0205
21 REBOUND ACID HYPERSECRETION 62 0.0205
22 HEPATIC CYST 69 0.0203
23 PRODUCT ADMINISTRATION INTERRUPTED 154 0.0196
24 OXYGEN CONSUMPTION INCREASED 46 0.0192
25 ATRIAL FLUTTER 151 0.0189
26 DEVICE INFUSION ISSUE 43 0.0173
27 SINUS BRADYCARDIA 163 0.0168
28 INFUSION SITE SWELLING 106 0.0168
29 ARTERIOSCLEROSIS CORONARY ARTERY 110 0.0166
30 VENTRICULAR EXTRASYSTOLES 170 0.0164
31 CORONARY ARTERY STENOSIS 82 0.0163
32 VENTRICULAR HYPOKINESIA 52 0.0162
33 INFUSION SITE ERYTHEMA 136 0.0161
34 TRICUSPID VALVE INCOMPETENCE 128 0.0161
35 HYPERVOLAEMIA 79 0.0160
36 CORONARY ARTERY OCCLUSION 218 0.0159
37 CARDIOGENIC SHOCK 228 0.0159
38 ATRIAL FIBRILLATION 1545 0.0158
39 MITRAL VALVE INCOMPETENCE 178 0.0157
40 INFUSION SITE PAIN 202 0.0157
41 BUNDLE BRANCH BLOCK LEFT 66 0.0155
42 ATRIOVENTRICULAR BLOCK FIRST DEGREE 67 0.0154
43 ANGINA UNSTABLE 100 0.0154
44 HYPERURICAEMIA 63 0.0153
45 ATRIOVENTRICULAR BLOCK SECOND DEGREE 46 0.0151
46 LEFT VENTRICULAR DYSFUNCTION 100 0.0149
47 HIGH DENSITY LIPOPROTEIN DECREASED 49 0.0147
48 HAEMORRHAGIC ANAEMIA 63 0.0143
49 HEART RATE ABNORMAL 79 0.0142
50 AORTIC STENOSIS 49 0.0141
51 LISTLESS 46 0.0139
52 INFUSION SITE PRURITUS 44 0.0139
53 VENTRICULAR ARRHYTHMIA 51 0.0139
54 AORTIC VALVE INCOMPETENCE 59 0.0139
55 PRE-EXISTING CONDITION IMPROVED 86 0.0138
56 CAROTID ARTERY STENOSIS 48 0.0137
57 HIATUS HERNIA 177 0.0137
58 STENT PLACEMENT 108 0.0134
59 CARDIAC FAILURE CHRONIC 57 0.0134
60 ISCHAEMIC CARDIOMYOPATHY 41 0.0134
61 CARDIAC FAILURE ACUTE 89 0.0133
62 CARDIAC FLUTTER 86 0.0133
63 DYSPNOEA EXERTIONAL 496 0.0132
64 ATRIOVENTRICULAR BLOCK 101 0.0131
65 BLOOD PRESSURE ABNORMAL 259 0.0130
66 HYPERLIPIDAEMIA 154 0.0129
67 END STAGE RENAL DISEASE 235 0.0129
68 ATRIOVENTRICULAR BLOCK COMPLETE 86 0.0128
69 CORONARY ARTERY DISEASE 388 0.0128
70 BLOOD CHOLESTEROL ABNORMAL 59 0.0128
71 EXTRASYSTOLES 89 0.0127
72 ORTHOPNOEA 40 0.0125
73 HEART RATE IRREGULAR 282 0.0125
74 EYE PAIN 704 0.0125
75 GOUT 223 0.0124
76 EJECTION FRACTION DECREASED 193 0.0124
77 HYPERTENSIVE CRISIS 138 0.0124
78 HAEMOGLOBIN INCREASED 56 0.0123
79 LEFT VENTRICULAR FAILURE 42 0.0122
80 SNORING 46 0.0122
81 BODY HEIGHT DECREASED 130 0.0121
82 VENTRICULAR TACHYCARDIA 200 0.0121
83 DIZZINESS POSTURAL 115 0.0118
84 WOUND DEHISCENCE 40 0.0118
85 DIABETIC NEUROPATHY 57 0.0115
86 BLOOD MAGNESIUM DECREASED 98 0.0113
87 HYPERCHOLESTEROLAEMIA 109 0.0113
88 CATHETERISATION CARDIAC 50 0.0113
89 BENIGN PROSTATIC HYPERPLASIA 58 0.0112
90 LOWER GASTROINTESTINAL HAEMORRHAGE 83 0.0112
91 ARRHYTHMIA 528 0.0111
92 FOREIGN BODY SENSATION IN EYES 71 0.0111
93 MULTIPLE ALLERGIES 87 0.0111
94 SUPRAVENTRICULAR TACHYCARDIA 106 0.0111
95 BRADYCARDIA 583 0.0110
96 PROTHROMBIN TIME PROLONGED 65 0.0109
97 RENAL CYST 86 0.0108
98 INCREASED TENDENCY TO BRUISE 99 0.0107
99 OCULAR DISCOMFORT 120 0.0107
100 SKIN ABRASION 50 0.0106
101 GLOMERULAR FILTRATION RATE DECREASED 130 0.0106
102 ARTERIAL OCCLUSIVE DISEASE 83 0.0105
103 PULMONARY HYPERTENSION 219 0.0105
104 HYPOMAGNESAEMIA 146 0.0105
105 PROSTATOMEGALY 41 0.0104
106 HYPOVOLAEMIA 61 0.0104
107 ANGINA PECTORIS 297 0.0104
108 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 43 0.0103
109 WEIGHT FLUCTUATION 108 0.0103
110 GLUCOSE TOLERANCE IMPAIRED 61 0.0103
111 INFLAMMATORY MARKER INCREASED 51 0.0103
112 FULL BLOOD COUNT DECREASED 207 0.0103
113 THYROID MASS 39 0.0102
114 ACUTE MYOCARDIAL INFARCTION 299 0.0101
115 RENAL FUNCTION TEST ABNORMAL 47 0.0101
116 CHRONIC KIDNEY DISEASE 768 0.0101
117 PERIPHERAL VASCULAR DISORDER 52 0.0101
118 VITAMIN D DEFICIENCY 98 0.0100
119 LEFT VENTRICULAR HYPERTROPHY 43 0.0100
120 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 41 0.0100
121 BLOOD POTASSIUM INCREASED 163 0.0100
122 ORTHOSTATIC HYPOTENSION 174 0.0100
123 CHOKING SENSATION 55 0.0100
124 HEART RATE DECREASED 350 0.0100
125 TORSADE DE POINTES 78 0.0099
126 VENTRICULAR FIBRILLATION 110 0.0099
127 CARDIAC PACEMAKER INSERTION 59 0.0099
128 INTERNATIONAL NORMALISED RATIO DECREASED 40 0.0099
129 PROTEIN URINE PRESENT 49 0.0098
130 CARDIAC VALVE DISEASE 56 0.0098
131 PHOTOPHOBIA 180 0.0096
132 RENAL FAILURE CHRONIC 73 0.0095
133 SLEEP APNOEA SYNDROME 181 0.0095
134 PRODUCTIVE COUGH 450 0.0094
135 HYPERKALAEMIA 330 0.0094
136 BUNDLE BRANCH BLOCK RIGHT 43 0.0094
137 CARDIAC MURMUR 81 0.0094
138 ARTERIOSCLEROSIS 88 0.0093
139 UPPER-AIRWAY COUGH SYNDROME 77 0.0093
140 BLOOD PRESSURE FLUCTUATION 223 0.0093
141 HALLUCINATIONS, MIXED 39 0.0093
142 PELVIC FRACTURE 72 0.0092
143 CARDIAC FAILURE CONGESTIVE 741 0.0092
144 GROIN PAIN 81 0.0092
145 BLOOD POTASSIUM DECREASED 277 0.0092
146 ACUTE RESPIRATORY FAILURE 177 0.0092
147 BLOOD SODIUM DECREASED 173 0.0092
148 BLOOD UREA INCREASED 153 0.0091
149 ANEURYSM 45 0.0090
150 POSTOPERATIVE WOUND INFECTION 61 0.0090
151 BLOOD PRESSURE SYSTOLIC DECREASED 41 0.0090
152 HAEMORRHOIDAL HAEMORRHAGE 44 0.0090
153 RALES 52 0.0089
154 PRODUCT DISTRIBUTION ISSUE 83 0.0089
155 FAECALOMA 49 0.0089
156 BREATH SOUNDS ABNORMAL 44 0.0089
157 SPINAL OSTEOARTHRITIS 78 0.0089
158 CORONARY ARTERIAL STENT INSERTION 45 0.0089
159 FLUID RETENTION 450 0.0088
160 OXYGEN SATURATION DECREASED 497 0.0088
161 RHINITIS ALLERGIC 39 0.0088
162 CEREBRAL ISCHAEMIA 45 0.0087
163 IMMOBILE 38 0.0087
164 HEART RATE INCREASED 860 0.0087
165 ELECTROCARDIOGRAM ABNORMAL 68 0.0087
166 APLASTIC ANAEMIA 45 0.0086
167 VASCULAR DEVICE INFECTION 39 0.0086
168 HYPOTENSION 1712 0.0085
169 SOMNAMBULISM 56 0.0085
170 BLOOD PRESSURE INCREASED 1299 0.0085
171 NOCTURIA 103 0.0085
172 INTERNATIONAL NORMALISED RATIO INCREASED 241 0.0084
173 DECREASED ACTIVITY 91 0.0084
174 TASTE DISORDER 171 0.0084
175 CARDIAC FAILURE 674 0.0084
176 PERIPHERAL COLDNESS 115 0.0084
177 EXERCISE TOLERANCE DECREASED 48 0.0083
178 OROPHARYNGEAL DISCOMFORT 75 0.0083
179 SKIN HAEMORRHAGE 123 0.0083
180 NASAL DRYNESS 52 0.0083
181 HAEMATOCRIT DECREASED 164 0.0083
182 ANURIA 71 0.0082
183 RENAL CELL CARCINOMA 40 0.0082
184 EPISTAXIS 610 0.0081
185 TROPONIN INCREASED 62 0.0081
186 PROSTATIC SPECIFIC ANTIGEN INCREASED 112 0.0081
187 BLOOD PRESSURE DECREASED 540 0.0081
188 CARDIOMYOPATHY 120 0.0081
189 PULMONARY CONGESTION 107 0.0081
190 HOSPICE CARE 80 0.0081
191 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 422 0.0081
192 HAEMOPTYSIS 225 0.0081
193 JOINT DISLOCATION 85 0.0080
194 RED BLOOD CELL COUNT DECREASED 229 0.0080
195 SINUS DISORDER 158 0.0080
196 CARDIOMEGALY 98 0.0080
197 GASTRIC ULCER HAEMORRHAGE 44 0.0079
198 BRAIN FOG 124 0.0079
199 SINUS HEADACHE 47 0.0079
200 SKIN LACERATION 86 0.0079
201 EYE IRRITATION 455 0.0079
202 INSURANCE ISSUE 120 0.0078
203 FAECES SOFT 57 0.0078
204 BLOOD CREATININE INCREASED 511 0.0078
205 PRODUCT DOSE OMISSION IN ERROR 221 0.0078
206 AORTIC ANEURYSM 59 0.0077
207 BLOOD CALCIUM DECREASED 87 0.0077
208 HEAD INJURY 243 0.0077
209 CARDIAC OPERATION 66 0.0077
210 HYPOXIA 270 0.0077
211 GASTROINTESTINAL MOTILITY DISORDER 41 0.0077
212 PALPITATIONS 896 0.0076
213 HOT FLUSH 576 0.0076
214 CARDIAC DISORDER 713 0.0076
215 PLATELET COUNT ABNORMAL 46 0.0076
216 UROSEPSIS 70 0.0076
217 GASTROINTESTINAL HAEMORRHAGE 632 0.0076
218 VARICOSE VEIN 39 0.0075
219 SINUS TACHYCARDIA 107 0.0075
220 EYE DISCHARGE 78 0.0075
221 MENTAL STATUS CHANGES 208 0.0075
222 VITAMIN D DECREASED 64 0.0075
223 URINARY TRACT INFECTION 1277 0.0075
224 RENAL FAILURE 994 0.0075
225 POLYP 49 0.0075
226 OVERWEIGHT 40 0.0074
227 RESPIRATORY TRACT CONGESTION 118 0.0074
228 HYPERTENSION 1573 0.0074
229 COUGH 2081 0.0074
230 PRODUCT RESIDUE PRESENT 40 0.0074
231 ESCHERICHIA INFECTION 61 0.0074
232 LACRIMATION INCREASED 224 0.0074
233 HEPATIC STEATOSIS 138 0.0074
234 FULL BLOOD COUNT ABNORMAL 78 0.0074
235 LIMB INJURY 200 0.0074
236 HAEMOGLOBIN DECREASED 755 0.0073
237 RENAL FAILURE ACUTE 312 0.0073
238 IMPAIRED GASTRIC EMPTYING 100 0.0073
239 RHINORRHOEA 474 0.0073
240 SWELLING OF EYELID 46 0.0073
241 FAILURE TO THRIVE 38 0.0073
242 BOWEL MOVEMENT IRREGULARITY 56 0.0073
243 PULMONARY OEDEMA 327 0.0073
244 HYPOKALAEMIA 337 0.0073
245 RENAL INJURY 216 0.0073
246 PERICARDIAL EFFUSION 168 0.0073
247 INTERNAL HAEMORRHAGE 83 0.0073
248 HYPERKERATOSIS 40 0.0072
249 BLOOD IRON DECREASED 86 0.0072
250 SYNCOPE 724 0.0072
251 ERUCTATION 140 0.0072
252 PLEURAL EFFUSION 440 0.0072
253 HEAD DISCOMFORT 128 0.0072
254 THROAT IRRITATION 320 0.0071
255 CORONARY ARTERY BYPASS 41 0.0071
256 WALKING AID USER 47 0.0071
257 COLITIS ISCHAEMIC 48 0.0071
258 SCOLIOSIS 44 0.0071
259 DEHYDRATION 947 0.0071
260 SCIATICA 113 0.0071
261 INTENTIONAL DOSE OMISSION 202 0.0071
262 RETCHING 151 0.0071
263 HYDRONEPHROSIS 53 0.0071
264 CONTUSION 681 0.0071
265 GASTROENTERITIS VIRAL 127 0.0070
266 OBESITY 112 0.0070
267 ERYTHEMA OF EYELID 38 0.0070
268 UPPER RESPIRATORY TRACT INFECTION 324 0.0070
269 HYPERSOMNIA 201 0.0070
270 OEDEMA PERIPHERAL 853 0.0070
271 OSTEOPENIA 106 0.0070
272 ACUTE KIDNEY INJURY 1067 0.0070
273 PERIPHERAL SWELLING 1073 0.0070
274 MOUTH HAEMORRHAGE 51 0.0069
275 PRESYNCOPE 169 0.0069
276 SKIN ATROPHY 40 0.0069
277 RENAL TUBULAR NECROSIS 68 0.0069
278 MYOCARDIAL INFARCTION 1209 0.0069
279 CHEST PAIN 1282 0.0069
280 PERIORBITAL SWELLING 39 0.0069
281 ACUTE CORONARY SYNDROME 57 0.0069
282 DYSPNOEA 3873 0.0068
283 DERMATITIS CONTACT 78 0.0068
284 ONYCHOCLASIS 47 0.0068
285 SMALL INTESTINAL OBSTRUCTION 84 0.0068
286 SKIN ULCER 176 0.0068
287 LYMPHOEDEMA 47 0.0068
288 LUNG INFILTRATION 60 0.0068
289 APPETITE DISORDER 45 0.0068
290 DIVERTICULITIS 188 0.0068
291 BACK DISORDER 110 0.0068
292 TRANSIENT ISCHAEMIC ATTACK 228 0.0068
293 THYROID DISORDER 104 0.0067
294 RHABDOMYOLYSIS 281 0.0067
295 SCRATCH 71 0.0067
296 BLOOD CALCIUM INCREASED 59 0.0067
297 ELECTROLYTE IMBALANCE 78 0.0067
298 PULMONARY MASS 100 0.0067
299 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 114 0.0067
300 RIB FRACTURE 138 0.0067
301 CHEST DISCOMFORT 686 0.0067
302 FALL 2215 0.0066
303 MELAENA 146 0.0066
304 URINE ODOUR ABNORMAL 39 0.0066
305 MALNUTRITION 74 0.0066
306 IRON DEFICIENCY ANAEMIA 61 0.0066
307 MUSCULOSKELETAL CHEST PAIN 102 0.0066
308 HAEMARTHROSIS 59 0.0066
309 LEUKOCYTOSIS 119 0.0066
310 DRUG INTERACTION 1042 0.0066
311 PRODUCT SUBSTITUTION ISSUE 378 0.0066
312 BRONCHITIS 485 0.0065
313 CHOLECYSTITIS 78 0.0065
314 RESPIRATION ABNORMAL 45 0.0065
315 ASTHENIA 2453 0.0065
316 GASTROOESOPHAGEAL REFLUX DISEASE 525 0.0065
317 SINUS CONGESTION 88 0.0065
318 MUSCULOSKELETAL DISCOMFORT 112 0.0065
319 SKIN FISSURES 127 0.0065
320 POLLAKIURIA 271 0.0065
321 DIZZINESS 3236 0.0065
322 INTERVERTEBRAL DISC DEGENERATION 60 0.0065
323 UPPER GASTROINTESTINAL HAEMORRHAGE 109 0.0065
324 ARTHROPOD BITE 48 0.0065
325 ORAL PAIN 145 0.0065
326 DIVERTICULUM 46 0.0065
327 DECREASED APPETITE 1503 0.0065
328 DRY EYE 323 0.0065
329 LOCALISED INFECTION 156 0.0064
330 HALLUCINATION, VISUAL 136 0.0064
331 PHARYNGEAL SWELLING 63 0.0064
332 CONSTIPATION 1404 0.0064
333 INITIAL INSOMNIA 66 0.0064
334 RESTLESS LEGS SYNDROME 116 0.0064
335 BALANCE DISORDER 551 0.0064
336 SLUGGISHNESS 65 0.0064
337 FATIGUE 4958 0.0064
338 CIRCULATORY COLLAPSE 108 0.0063
339 ANAL INCONTINENCE 57 0.0063
340 BLOOD URINE PRESENT 120 0.0063
341 NEPHROPATHY 59 0.0063
342 DIARRHOEA 4072 0.0063
343 WHITE BLOOD CELL COUNT ABNORMAL 40 0.0063
344 PRODUCT DOSE OMISSION ISSUE 1843 0.0063
345 INFUSION SITE EXTRAVASATION 39 0.0063
346 WEIGHT DECREASED 1746 0.0062
347 EMPHYSEMA 63 0.0062
348 URINARY INCONTINENCE 185 0.0062
349 MYOCARDIAL ISCHAEMIA 71 0.0062
350 GINGIVAL BLEEDING 85 0.0062
351 PRODUCT USE COMPLAINT 98 0.0062
352 CYSTITIS 198 0.0062
353 HAEMATURIA 212 0.0062
354 FLANK PAIN 58 0.0062
355 BLOOD TRIGLYCERIDES INCREASED 109 0.0062
356 FACIAL PAIN 55 0.0062
357 BASAL CELL CARCINOMA 96 0.0061
358 ORAL CANDIDIASIS 81 0.0061
359 EYE HAEMORRHAGE 82 0.0061
360 EAR DISCOMFORT 63 0.0061
361 SCAB 70 0.0061
362 RIGHT VENTRICULAR FAILURE 43 0.0061
363 AGEUSIA 153 0.0061
364 HYPOCALCAEMIA 116 0.0061
365 ECCHYMOSIS 42 0.0061
366 EYE INFECTION 69 0.0061
367 ATELECTASIS 59 0.0061
368 SPINAL FRACTURE 122 0.0061
369 PNEUMONIA 1971 0.0061
370 BLOOD THYROID STIMULATING HORMONE INCREASED 56 0.0061
371 MUSCULAR WEAKNESS 690 0.0061
372 PLATELET COUNT DECREASED 647 0.0061
373 TOOTH INFECTION 80 0.0061
374 HAEMOGLOBIN ABNORMAL 39 0.0061
375 INCONTINENCE 64 0.0060
376 OESOPHAGITIS 66 0.0060
377 NEUROPATHY PERIPHERAL 574 0.0060
378 MYELODYSPLASTIC SYNDROME 87 0.0060
379 HALLUCINATION 453 0.0060
380 SINUSITIS 616 0.0060
381 SPUTUM DISCOLOURED 57 0.0060
382 FAECES DISCOLOURED 130 0.0060
383 URINARY RETENTION 200 0.0060
384 RESPIRATORY TRACT INFECTION 156 0.0060
385 IMPAIRED QUALITY OF LIFE 86 0.0060
386 BACK INJURY 65 0.0060
387 GASTRITIS 157 0.0060
388 HEREDITARY ANGIOEDEMA 64 0.0060
389 URINE OUTPUT DECREASED 52 0.0059
390 HERNIA 115 0.0059
391 HAEMORRHOIDS 116 0.0059
392 ENCEPHALOPATHY 146 0.0059
393 HAEMATOMA 154 0.0059
394 ECONOMIC PROBLEM 90 0.0059
395 OEDEMA 322 0.0059
396 ILLNESS 611 0.0059
397 HYPOTHERMIA 60 0.0059
398 DYSPEPSIA 583 0.0059
399 TUBULOINTERSTITIAL NEPHRITIS 111 0.0059
400 DYSPHONIA 346 0.0059
401 HEPATOMEGALY 58 0.0059
402 HAEMORRHAGIC STROKE 46 0.0059
403 SKIN SWELLING 51 0.0059
404 PULMONARY THROMBOSIS 64 0.0059
405 LIGAMENT SPRAIN 58 0.0059
406 COVID-19 1028 0.0059
407 RESPIRATORY SYNCYTIAL VIRUS INFECTION 51 0.0059
408 CARPAL TUNNEL SYNDROME 82 0.0058
409 JOINT INJURY 125 0.0058
410 POLYNEUROPATHY 70 0.0058
411 HYPONATRAEMIA 329 0.0058
412 SECRETION DISCHARGE 73 0.0058
413 PAIN IN JAW 165 0.0058
414 RENAL DISORDER 271 0.0058
415 OCULAR HYPERAEMIA 276 0.0058
416 BLOOD CHOLESTEROL INCREASED 271 0.0058
417 CHROMATURIA 131 0.0058
418 SUBARACHNOID HAEMORRHAGE 59 0.0058
419 HAND FRACTURE 41 0.0058
420 LARGE INTESTINE POLYP 40 0.0058
421 UNRESPONSIVE TO STIMULI 149 0.0058
422 DECUBITUS ULCER 47 0.0058
423 COAGULOPATHY 96 0.0058
424 TENDERNESS 60 0.0058
425 CLOSTRIDIUM DIFFICILE COLITIS 61 0.0057
426 LIMB DISCOMFORT 178 0.0057
427 ABDOMINAL DISCOMFORT 961 0.0057
428 FOOT FRACTURE 108 0.0057
429 PLATELET COUNT INCREASED 74 0.0057
430 TACHYPNOEA 77 0.0057
431 RECALLED PRODUCT ADMINISTERED 54 0.0057
432 PETECHIAE 59 0.0056
433 BACK PAIN 1309 0.0056
434 BEDRIDDEN 74 0.0056
435 GAIT INABILITY 188 0.0056
436 FLATULENCE 319 0.0056
437 SNEEZING 126 0.0056
438 MICTURITION URGENCY 64 0.0056
439 DYSURIA 206 0.0056
440 WRIST FRACTURE 67 0.0056
441 INTERVERTEBRAL DISC PROTRUSION 122 0.0056
442 GASTROINTESTINAL INFECTION 50 0.0056
443 HIP FRACTURE 179 0.0056
444 SENSITIVE SKIN 41 0.0056
445 LOW DENSITY LIPOPROTEIN INCREASED 43 0.0055
446 CONCUSSION 43 0.0055
447 HAEMORRHAGE INTRACRANIAL 83 0.0055
448 GASTROINTESTINAL PAIN 61 0.0055
449 BLADDER DISORDER 55 0.0055
450 DELUSION 86 0.0055
451 TOOTH DISORDER 123 0.0055
452 FEEDING DISORDER 112 0.0055
453 STAPHYLOCOCCAL INFECTION 182 0.0055
454 MIDDLE INSOMNIA 103 0.0055
455 COVID-19 PNEUMONIA 65 0.0055
456 ACIDOSIS 42 0.0055
457 VITREOUS FLOATERS 54 0.0055
458 SKIN DISCOLOURATION 252 0.0055
459 HYPOACUSIS 236 0.0055
460 NEPHROLITHIASIS 251 0.0055
461 GASTRIC ULCER 104 0.0055
462 NASAL CONGESTION 321 0.0055
463 DRY MOUTH 443 0.0055
464 CHOLELITHIASIS 179 0.0055
465 LABORATORY TEST ABNORMAL 161 0.0055
466 MACULAR DEGENERATION 65 0.0054
467 DEMENTIA 152 0.0054
468 ANAEMIA 1035 0.0054
469 CEREBRAL HAEMORRHAGE 194 0.0054
470 DIABETES MELLITUS 413 0.0054
471 THERAPY NON-RESPONDER 243 0.0054
472 SHOCK HAEMORRHAGIC 44 0.0054
473 COELIAC DISEASE 53 0.0054
474 POOR QUALITY SLEEP 116 0.0054
475 SPINAL DISORDER 51 0.0054
476 SPLENOMEGALY 63 0.0054
477 CARDIAC ARREST 441 0.0053
478 BLOOD PRESSURE SYSTOLIC INCREASED 104 0.0053
479 ARTHRITIS 419 0.0053
480 CARDIOVASCULAR DISORDER 135 0.0053
481 TYPE 2 DIABETES MELLITUS 179 0.0053
482 OSTEOARTHRITIS 225 0.0053
483 CATARACT 316 0.0053
484 KIDNEY INFECTION 104 0.0053
485 OROPHARYNGEAL PAIN 490 0.0053
486 POST PROCEDURAL INFECTION 43 0.0053
487 RENAL IMPAIRMENT 444 0.0053
488 FEELING COLD 147 0.0053
489 SEPSIS 588 0.0053
490 CANDIDA INFECTION 89 0.0053
491 WHITE BLOOD CELL COUNT DECREASED 570 0.0053
492 DEVICE OCCLUSION 74 0.0053
493 SLEEP DISORDER 371 0.0053
494 CELLULITIS 264 0.0052
495 TEMPERATURE INTOLERANCE 54 0.0052
496 VIRAL INFECTION 174 0.0052
497 METABOLIC ACIDOSIS 167 0.0052
498 COLD SWEAT 92 0.0052
499 LIVER FUNCTION TEST INCREASED 112 0.0052
500 MUSCLE ATROPHY 66 0.0052
501 GAIT DISTURBANCE 996 0.0052
502 SKIN CANCER 112 0.0052
503 FOOD ALLERGY 40 0.0052
504 TACHYCARDIA 460 0.0052
505 BLOOD ALBUMIN DECREASED 41 0.0052
506 STOMATITIS 313 0.0052
507 POST PROCEDURAL COMPLICATION 99 0.0052
508 THERAPY INTERRUPTED 368 0.0051
509 SARS-COV-2 TEST POSITIVE 68 0.0051
510 QUALITY OF LIFE DECREASED 69 0.0051
511 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 247 0.0051
512 APATHY 75 0.0051
513 ROTATOR CUFF SYNDROME 66 0.0051
514 BLOOD TEST ABNORMAL 72 0.0051
515 PNEUMONIA BACTERIAL 47 0.0051
516 HAEMODYNAMIC INSTABILITY 39 0.0051
517 INFLUENZA 570 0.0051
518 PULMONARY ARTERIAL HYPERTENSION 74 0.0051
519 POST PROCEDURAL HAEMORRHAGE 59 0.0051
520 NECK PAIN 283 0.0051
521 EYE PRURITUS 170 0.0051
522 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 911 0.0050
523 LOSS OF CONSCIOUSNESS 647 0.0050
524 ASCITES 148 0.0050
525 SPINAL OPERATION 62 0.0050
526 ULCER 80 0.0050
527 EYE SWELLING 187 0.0050
528 BLOOD COUNT ABNORMAL 76 0.0050
529 POLYURIA 41 0.0050
530 THROMBOSIS 402 0.0050
531 CONFUSIONAL STATE 806 0.0050
532 WHITE BLOOD CELL COUNT INCREASED 191 0.0050
533 PLASMA CELL MYELOMA 194 0.0050
534 SPINAL COMPRESSION FRACTURE 41 0.0050
535 HYPOTHYROIDISM 158 0.0049
536 GENERALISED OEDEMA 61 0.0049
537 THIRST 88 0.0049
538 ELECTROCARDIOGRAM QT PROLONGED 177 0.0049
539 NAIL DISORDER 43 0.0049
540 MEMORY IMPAIRMENT 675 0.0049
541 RESPIRATORY FAILURE 358 0.0049
542 RENAL PAIN 52 0.0049
543 SKIN INFECTION 55 0.0049
544 PAIN IN EXTREMITY 1439 0.0049
545 TOOTHACHE 88 0.0049
546 NIGHT SWEATS 156 0.0048
547 NERVOUSNESS 252 0.0048
548 VISION BLURRED 661 0.0048
549 NAUSEA 3810 0.0048
550 HYPOPHAGIA 123 0.0048
551 ABDOMINAL DISTENSION 502 0.0048
552 RECTAL HAEMORRHAGE 206 0.0048
553 DIALYSIS 68 0.0048
554 IMPAIRED HEALING 157 0.0048
555 ANKLE FRACTURE 74 0.0048
556 NASOPHARYNGITIS 881 0.0048
557 FUNGAL INFECTION 159 0.0048
558 HIP ARTHROPLASTY 73 0.0048
559 CEREBROVASCULAR ACCIDENT 806 0.0048
560 LACTIC ACIDOSIS 154 0.0048
561 RESTLESSNESS 174 0.0047
562 EATING DISORDER 101 0.0047
563 HEADACHE 2968 0.0047
564 EAR PAIN 92 0.0047
565 APHONIA 66 0.0047
566 TINNITUS 217 0.0047
567 TOOTH ABSCESS 48 0.0047
568 INSOMNIA 1255 0.0047
569 HYPERCALCAEMIA 58 0.0047
570 DYSSTASIA 137 0.0047
571 RASH MACULAR 164 0.0047
572 RASH PRURITIC 254 0.0047
573 HERPES ZOSTER 269 0.0047
574 NERVE INJURY 52 0.0047
575 TRANSFUSION 49 0.0047
576 PRURITUS 1797 0.0047
577 PSEUDOMONAS INFECTION 40 0.0047
578 PRESCRIBED UNDERDOSE 93 0.0047
579 GASTROENTERITIS 68 0.0047
580 UNEVALUABLE EVENT 352 0.0046
581 DRY SKIN 621 0.0046
582 PRODUCT ADMINISTRATION ERROR 94 0.0046
583 LETHARGY 267 0.0046
584 MUSCLE SPASMS 850 0.0046
585 BLOOD ALKALINE PHOSPHATASE INCREASED 115 0.0046
586 MULTI-ORGAN FAILURE 80 0.0046
587 GLAUCOMA 89 0.0046
588 BURSITIS 56 0.0046
589 DYSPHAGIA 437 0.0046
590 GALLBLADDER DISORDER 82 0.0046
591 NEUTROPHIL COUNT INCREASED 47 0.0046
592 DIPLOPIA 119 0.0046
593 CLOSTRIDIUM DIFFICILE INFECTION 100 0.0046
594 ANOREXIA 59 0.0046
595 UPPER LIMB FRACTURE 91 0.0046
596 FEELING ABNORMAL 1089 0.0045
597 SUBDURAL HAEMATOMA 65 0.0045
598 BLISTER 255 0.0045
599 TREATMENT NONCOMPLIANCE 248 0.0045
600 DELIRIUM 157 0.0045
601 OSTEOPOROSIS 186 0.0045
602 DRUG EFFECT LESS THAN EXPECTED 67 0.0045
603 MYALGIA 768 0.0045
604 VERTIGO 275 0.0045
605 LUNG DISORDER 221 0.0045
606 EAR INFECTION 120 0.0045
607 BONE PAIN 264 0.0045
608 FEAR 121 0.0045
609 FLUSHING 457 0.0045
610 WHEEZING 266 0.0045
611 SPEECH DISORDER 235 0.0045
612 IRRITABLE BOWEL SYNDROME 96 0.0045
613 IMMUNE SYSTEM DISORDER 59 0.0045
614 BLOOD GLUCOSE FLUCTUATION 49 0.0045
615 DISORIENTATION 177 0.0045
616 SURGERY 261 0.0044
617 BONE DISORDER 81 0.0044
618 BLOOD GLUCOSE ABNORMAL 82 0.0044
619 GASTROINTESTINAL DISORDER 396 0.0044
620 ANHEDONIA 116 0.0044
621 HYPOKINESIA 64 0.0044
622 CHOKING 86 0.0044
623 APHASIA 133 0.0044
624 HYPERGLYCAEMIA 160 0.0044
625 ORAL DISCOMFORT 61 0.0044
626 EXOSTOSIS 40 0.0044
627 CHOLECYSTECTOMY 50 0.0044
628 KNEE OPERATION 43 0.0044
629 IMMUNODEFICIENCY 65 0.0044
630 HYPERHIDROSIS 561 0.0044
631 TOOTH FRACTURE 48 0.0043
632 SKIN EXFOLIATION 367 0.0043
633 DIABETES MELLITUS INADEQUATE CONTROL 77 0.0043
634 PRODUCT AVAILABILITY ISSUE 99 0.0043
635 ABDOMINAL PAIN UPPER 894 0.0043
636 PRODUCT USE IN UNAPPROVED INDICATION 1076 0.0043
637 NERVE COMPRESSION 40 0.0043
638 CYTOPENIA 53 0.0043
639 THERAPY PARTIAL RESPONDER 67 0.0043
640 HYPERTHYROIDISM 62 0.0043
641 PULMONARY FIBROSIS 82 0.0043
642 FLUID OVERLOAD 62 0.0043
643 SQUAMOUS CELL CARCINOMA 40 0.0042
644 SOMNOLENCE 855 0.0042
645 DISCOMFORT 259 0.0042
646 DRY THROAT 43 0.0042
647 INABILITY TO AFFORD MEDICATION 42 0.0042
648 KNEE ARTHROPLASTY 89 0.0042
649 PNEUMOTHORAX 67 0.0042
650 INTENTIONAL PRODUCT MISUSE 369 0.0042
651 DERMATITIS ATOPIC 222 0.0042
652 HYPOTONIA 42 0.0042
653 DEAFNESS 110 0.0042
654 AUTOIMMUNE DISORDER 41 0.0042
655 SCAR 72 0.0042
656 HEPATIC CIRRHOSIS 79 0.0042
657 ISCHAEMIC STROKE 75 0.0042
658 HYPOAESTHESIA 627 0.0042
659 HYPOAESTHESIA ORAL 63 0.0042
660 JOINT RANGE OF MOTION DECREASED 56 0.0042
661 WEIGHT INCREASED 935 0.0042
662 DRUG LEVEL INCREASED 69 0.0042
663 DENTAL CARIES 46 0.0042
664 ARTHRALGIA 1726 0.0041
665 INCREASED APPETITE 79 0.0041
666 ABNORMAL DREAMS 114 0.0041
667 ECZEMA 216 0.0041
668 DEPRESSION 935 0.0041
669 TREMOR 682 0.0041
670 LIVER FUNCTION TEST ABNORMAL 119 0.0041
671 ASPARTATE AMINOTRANSFERASE INCREASED 217 0.0041
672 SKIN LESION 112 0.0041
673 BACTERIAL INFECTION 76 0.0041
674 DYSARTHRIA 153 0.0041
675 LOWER LIMB FRACTURE 78 0.0041
676 VOMITING 1908 0.0041
677 MOBILITY DECREASED 290 0.0040
678 VISUAL IMPAIRMENT 500 0.0040
679 DYSGEUSIA 299 0.0040
680 ILEUS 50 0.0040
681 GLOSSODYNIA 90 0.0040
682 ASPIRATION 44 0.0040
683 SWOLLEN TONGUE 125 0.0040
684 BRONCHOSPASM 57 0.0040
685 NEURALGIA 97 0.0040
686 NIGHTMARE 138 0.0040
687 BLOOD GLUCOSE DECREASED 191 0.0040
688 BLOOD LACTATE DEHYDROGENASE INCREASED 63 0.0040
689 SWELLING 372 0.0040
690 ANXIETY 1130 0.0040
691 DRUG TOXICITY 54 0.0040
692 HEMIPARESIS 67 0.0040
693 DEEP VEIN THROMBOSIS 257 0.0040
694 HAEMATOCHEZIA 217 0.0039
695 RASH 1713 0.0039
696 BLOOD CREATINE PHOSPHOKINASE INCREASED 113 0.0039
697 COGNITIVE DISORDER 183 0.0039
698 PANCREATITIS ACUTE 88 0.0039
699 MUSCULOSKELETAL PAIN 205 0.0039
700 TRANSAMINASES INCREASED 87 0.0039
701 GASTRIC HAEMORRHAGE 45 0.0039
702 AMNESIA 254 0.0039
703 LYMPHOCYTE COUNT DECREASED 69 0.0039
704 HALLUCINATION, AUDITORY 62 0.0039
705 ASTHMA 439 0.0039
706 PANCYTOPENIA 217 0.0039
707 HYPOGLYCAEMIA 188 0.0039
708 DISTURBANCE IN ATTENTION 209 0.0039
709 HEPATIC ENZYME INCREASED 264 0.0039
710 METASTASES TO LIVER 68 0.0039
711 CHILLS 452 0.0039
712 MULTIPLE ORGAN DYSFUNCTION SYNDROME 109 0.0038
713 MUSCULOSKELETAL DISORDER 73 0.0038
714 PRODUCT DOSE OMISSION 250 0.0038
715 HAEMORRHAGE 399 0.0038
716 ERECTILE DYSFUNCTION 98 0.0038
717 THINKING ABNORMAL 71 0.0038
718 COORDINATION ABNORMAL 53 0.0038
719 MALAISE 1662 0.0038
720 FOOT DEFORMITY 42 0.0038
721 PNEUMONITIS 103 0.0038
722 BURNING SENSATION 265 0.0038
723 PAIN 2316 0.0038
724 POOR VENOUS ACCESS 39 0.0038
725 OSTEOMYELITIS 68 0.0038
726 PHOTOSENSITIVITY REACTION 62 0.0038
727 HAEMATEMESIS 95 0.0037
728 PROTEINURIA 71 0.0037
729 MASS 52 0.0037
730 INFECTION 537 0.0037
731 SEPTIC SHOCK 161 0.0037
732 RESPIRATORY DISTRESS 102 0.0037
733 MENTAL IMPAIRMENT 89 0.0037
734 SPINAL PAIN 43 0.0037
735 CONTRAINDICATED PRODUCT ADMINISTERED 111 0.0037
736 BLOOD BILIRUBIN INCREASED 99 0.0037
737 MALIGNANT MELANOMA 49 0.0037
738 SHOCK 84 0.0036
739 ALANINE AMINOTRANSFERASE INCREASED 224 0.0036
740 TOXICITY TO VARIOUS AGENTS 615 0.0036
741 JOINT SWELLING 440 0.0036
742 MUSCLE TIGHTNESS 59 0.0036
743 PARALYSIS 52 0.0036
744 CYANOSIS 57 0.0036
745 JOINT STIFFNESS 95 0.0036
746 CONDITION AGGRAVATED 1099 0.0036
747 THERAPEUTIC RESPONSE UNEXPECTED 162 0.0036
748 PULMONARY EMBOLISM 342 0.0036
749 GENERAL PHYSICAL HEALTH DETERIORATION 416 0.0036
750 METASTASES TO BONE 59 0.0036
751 ACUTE HEPATIC FAILURE 49 0.0036
752 PRODUCT PRESCRIBING ISSUE 78 0.0036
753 DERMATITIS ALLERGIC 45 0.0036
754 DRUG INTOLERANCE 345 0.0036
755 FEELING JITTERY 68 0.0036
756 TENDON RUPTURE 44 0.0036
757 CEREBRAL INFARCTION 87 0.0036
758 THERAPEUTIC RESPONSE SHORTENED 118 0.0036
759 METASTASES TO LUNG 41 0.0035
760 DEVICE FAILURE 54 0.0035
761 PRODUCT TASTE ABNORMAL 48 0.0035
762 RESPIRATORY DISORDER 106 0.0035
763 OFF LABEL USE 3102 0.0035
764 FEELING HOT 217 0.0035
765 BLOOD GLUCOSE INCREASED 666 0.0035
766 PARAESTHESIA 556 0.0035
767 ARTHROPATHY 196 0.0035
768 VASCULITIS 41 0.0035
769 ADVERSE DRUG REACTION 316 0.0035
770 INTENTIONAL PRODUCT USE ISSUE 308 0.0035
771 THROMBOCYTOPENIA 393 0.0035
772 EXPOSURE VIA SKIN CONTACT 91 0.0035
773 RESPIRATORY DEPRESSION 43 0.0035
774 MUSCLE SPASTICITY 43 0.0035
775 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 192 0.0035
776 HOSPITALISATION 537 0.0035
777 DERMATITIS 73 0.0035
778 DRUG-INDUCED LIVER INJURY 109 0.0035
779 WOUND 97 0.0035
780 PANIC ATTACK 126 0.0035
781 PALLOR 94 0.0035
782 HUNGER 48 0.0034
783 DEVICE RELATED INFECTION 53 0.0034
784 ALOPECIA 676 0.0034
785 IMPAIRED DRIVING ABILITY 39 0.0034
786 LUNG INFECTION 53 0.0034
787 ACUTE RESPIRATORY DISTRESS SYNDROME 60 0.0034
788 PANCREATITIS 179 0.0034
789 CYST 42 0.0034
790 COLITIS 128 0.0034
791 TOOTH EXTRACTION 42 0.0034
792 DEVICE USE ISSUE 59 0.0034
793 PRODUCT PHYSICAL ISSUE 68 0.0034
794 BACTERAEMIA 40 0.0034
795 GLYCOSYLATED HAEMOGLOBIN INCREASED 85 0.0034
796 DEPRESSED MOOD 178 0.0034
797 NEOPLASM PROGRESSION 117 0.0034
798 PNEUMONIA ASPIRATION 84 0.0034
799 SWELLING FACE 218 0.0033
800 PRODUCT USE ISSUE 629 0.0033
801 EYE DISORDER 110 0.0033
802 GAMMA-GLUTAMYLTRANSFERASE INCREASED 74 0.0033
803 LYMPHADENOPATHY 118 0.0033
804 PHARYNGITIS 41 0.0033
805 ABDOMINAL PAIN 764 0.0033
806 BODY TEMPERATURE INCREASED 67 0.0033
807 ACCIDENT 39 0.0033
808 INTESTINAL OBSTRUCTION 123 0.0033
809 BRAIN OEDEMA 41 0.0032
810 LEUKOPENIA 162 0.0032
811 SKIN DISORDER 108 0.0032
812 CONJUNCTIVITIS 60 0.0032
813 ORAL HERPES 63 0.0032
814 COLON CANCER 48 0.0032
815 DISEASE RECURRENCE 153 0.0032
816 PARAESTHESIA ORAL 46 0.0032
817 HEPATIC FAILURE 96 0.0032
818 INJURY 222 0.0032
819 CARDIO-RESPIRATORY ARREST 132 0.0032
820 LIP SWELLING 105 0.0031
821 PRURITUS GENERALISED 68 0.0031
822 ACCIDENTAL OVERDOSE 115 0.0031
823 INJECTION SITE IRRITATION 40 0.0031
824 PHARYNGEAL OEDEMA 48 0.0031
825 SENSORY DISTURBANCE 50 0.0031
826 HYPERSENSITIVITY 578 0.0031
827 NEUTROPHIL COUNT DECREASED 126 0.0031
828 MENTAL DISORDER 134 0.0031
829 DEATH 2651 0.0031
830 MUSCULOSKELETAL STIFFNESS 269 0.0031
831 LIVER DISORDER 136 0.0031
832 ERYTHEMA 628 0.0031
833 MOVEMENT DISORDER 98 0.0030
834 THERAPY CESSATION 156 0.0030
835 MIGRAINE 290 0.0030
836 DISABILITY 60 0.0030
837 COMPLICATION ASSOCIATED WITH DEVICE 44 0.0030
838 C-REACTIVE PROTEIN INCREASED 110 0.0030
839 ABDOMINAL PAIN LOWER 76 0.0030
840 FIBROMYALGIA 73 0.0030
841 INFLUENZA LIKE ILLNESS 246 0.0030
842 BLINDNESS UNILATERAL 42 0.0030
843 STEVENS-JOHNSON SYNDROME 66 0.0030
844 ADVERSE EVENT 272 0.0029
845 MUSCLE TWITCHING 68 0.0029
846 METASTASES TO CENTRAL NERVOUS SYSTEM 38 0.0029
847 AGITATION 216 0.0029
848 DEPRESSED LEVEL OF CONSCIOUSNESS 116 0.0029
849 PYREXIA 1010 0.0029
850 ANGIOEDEMA 129 0.0029
851 RASH ERYTHEMATOUS 139 0.0029
852 FACE OEDEMA 49 0.0029
853 CYTOKINE RELEASE SYNDROME 58 0.0029
854 ACTIVITIES OF DAILY LIVING IMPAIRED 57 0.0029
855 ROAD TRAFFIC ACCIDENT 120 0.0029
856 RESPIRATORY ARREST 79 0.0029
857 RASH PAPULAR 64 0.0029
858 FREQUENT BOWEL MOVEMENTS 77 0.0028
859 THERAPEUTIC RESPONSE DECREASED 172 0.0028
860 THERAPEUTIC PRODUCT EFFECT DECREASED 127 0.0028
861 COMA 135 0.0028
862 PSORIATIC ARTHROPATHY 115 0.0028
863 ILL-DEFINED DISORDER 172 0.0028
864 PAIN OF SKIN 76 0.0028
865 GASTRIC DISORDER 96 0.0028
866 PARANOIA 48 0.0028
867 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 198 0.0028
868 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 64 0.0027
869 PHARMACEUTICAL PRODUCT COMPLAINT 71 0.0027
870 SEIZURE 315 0.0027
871 PRODUCT QUALITY ISSUE 370 0.0027
872 URTICARIA 453 0.0027
873 NEOPLASM MALIGNANT 179 0.0027
874 FRACTURE 50 0.0026
875 THROAT TIGHTNESS 71 0.0026
876 INFLAMMATION 135 0.0026
877 MEDICATION ERROR 145 0.0026
878 PROCEDURAL PAIN 72 0.0026
879 DYSKINESIA 105 0.0026
880 PRODUCT DISPENSING ERROR 56 0.0026
881 INJECTION SITE MASS 95 0.0026
882 LUNG NEOPLASM MALIGNANT 105 0.0026
883 COMPLETED SUICIDE 211 0.0025
884 BLINDNESS 103 0.0025
885 JAUNDICE 68 0.0025
886 LIVER INJURY 62 0.0025
887 PRODUCT PRESCRIBING ERROR 60 0.0025
888 ACUTE MYELOID LEUKAEMIA 39 0.0025
889 INCORRECT DOSE ADMINISTERED 571 0.0025
890 DRUG ERUPTION 44 0.0025
891 PSORIASIS 324 0.0025
892 PSYCHOTIC DISORDER 73 0.0025
893 RASH GENERALISED 64 0.0025
894 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 495 0.0024
895 FEBRILE NEUTROPENIA 162 0.0024
896 FEMUR FRACTURE 74 0.0024
897 MALIGNANT NEOPLASM PROGRESSION 244 0.0024
898 DRUG INEFFECTIVE 3139 0.0024
899 HEPATOTOXICITY 53 0.0024
900 NEUTROPENIA 323 0.0024
901 MULTIPLE FRACTURES 39 0.0024
902 SUICIDE ATTEMPT 142 0.0023
903 DISEASE PROGRESSION 275 0.0023
904 MOOD ALTERED 63 0.0023
905 RHEUMATOID ARTHRITIS 262 0.0023
906 EXTRA DOSE ADMINISTERED 93 0.0023
907 INJECTION SITE PRURITUS 153 0.0023
908 INJECTION SITE RASH 70 0.0023
909 DRUG DOSE OMISSION 373 0.0023
910 INFUSION RELATED REACTION 148 0.0022
911 VISUAL ACUITY REDUCED 73 0.0022
912 HEPATITIS 56 0.0022
913 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 155 0.0022
914 UNDERDOSE 159 0.0022
915 INTENTIONAL DRUG MISUSE 45 0.0022
916 AGRANULOCYTOSIS 40 0.0021
917 HEPATIC FUNCTION ABNORMAL 80 0.0021
918 CHOLESTASIS 41 0.0021
919 MOOD SWINGS 68 0.0021
920 ABNORMAL BEHAVIOUR 84 0.0021
921 RASH MACULO-PAPULAR 47 0.0021
922 NEEDLE ISSUE 61 0.0021
923 ABASIA 51 0.0021
924 MUCOSAL INFLAMMATION 54 0.0021
925 INTENTIONAL OVERDOSE 131 0.0020
926 INCORRECT PRODUCT ADMINISTRATION DURATION 44 0.0020
927 ANAPHYLACTIC REACTION 111 0.0020
928 DEVICE LEAKAGE 87 0.0020
929 DIABETIC KETOACIDOSIS 48 0.0020
930 INJECTION SITE BRUISING 158 0.0020
931 EMOTIONAL DISORDER 61 0.0020
932 INJECTION SITE PAIN 605 0.0020
933 DEVICE ISSUE 175 0.0019
934 PRODUCT PREPARATION ERROR 40 0.0019
935 IRRITABILITY 117 0.0019
936 DEVICE MALFUNCTION 136 0.0019
937 INTERSTITIAL LUNG DISEASE 93 0.0019
938 INJECTION SITE SWELLING 147 0.0019
939 INJECTION SITE URTICARIA 47 0.0019
940 PERITONITIS 39 0.0019
941 SYSTEMIC LUPUS ERYTHEMATOSUS 66 0.0019
942 CRYING 67 0.0018
943 EXPOSURE DURING PREGNANCY 113 0.0018
944 EMOTIONAL DISTRESS 220 0.0018
945 INJECTION SITE ERYTHEMA 225 0.0018
946 MOUTH ULCERATION 38 0.0018
947 AGGRESSION 90 0.0018
948 NERVOUS SYSTEM DISORDER 56 0.0018
949 CONVULSION 101 0.0018
950 ANGER 59 0.0017
951 INJECTION SITE HAEMORRHAGE 138 0.0017
952 OVERDOSE 354 0.0016
953 DRUG EFFECT DECREASED 88 0.0016
954 SUICIDAL IDEATION 147 0.0016
955 SEDATION 42 0.0016
956 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 54 0.0016
957 OSTEONECROSIS OF JAW 39 0.0016
958 WRONG TECHNIQUE IN DRUG USAGE PROCESS 57 0.0016
959 FOETAL EXPOSURE DURING PREGNANCY 127 0.0016
960 DRUG RESISTANCE 40 0.0016
961 EPILEPSY 47 0.0015
962 BREAST CANCER FEMALE 41 0.0015
963 MULTIPLE SCLEROSIS RELAPSE 104 0.0015
964 ACNE 115 0.0015
965 INJECTION SITE REACTION 104 0.0015
966 MULTIPLE SCLEROSIS 70 0.0015
967 SKIN IRRITATION 65 0.0014
968 DRUG ADMINISTRATION ERROR 43 0.0014
969 SKIN BURNING SENSATION 100 0.0014
970 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 64 0.0014
971 EXPIRED PRODUCT ADMINISTERED 45 0.0014
972 ACCIDENTAL EXPOSURE TO PRODUCT 139 0.0013
973 DEVICE DISLOCATION 58 0.0013
974 DRUG EFFECT INCOMPLETE 48 0.0013
975 VAGINAL HAEMORRHAGE 57 0.0013
976 LOWER RESPIRATORY TRACT INFECTION 58 0.0013
977 WITHDRAWAL SYNDROME 53 0.0013
978 OSTEONECROSIS 41 0.0012
979 BONE DENSITY DECREASED 38 0.0012
980 BREAST CANCER 111 0.0012
981 COLITIS ULCERATIVE 52 0.0012
982 PROSTATE CANCER 91 0.0011
983 DEVICE USE ERROR 39 0.0011
984 NO ADVERSE EVENT 196 0.0011
985 MATERNAL EXPOSURE DURING PREGNANCY 87 0.0010
986 DEVICE BREAKAGE 39 0.0010
987 PRODUCT STORAGE ERROR 84 0.0010
988 DEVICE DIFFICULT TO USE 63 0.0010
989 DRUG ABUSE 77 0.0009
990 TREATMENT FAILURE 68 0.0008
991 DRUG WITHDRAWAL SYNDROME 62 0.0007
992 BLADDER CANCER 38 0.0006
993 DRUG DEPENDENCE 51 0.0003